Ethnic differences in vascular adrenergic responsiveness have been implicated to be a potentially important mechanism which may be responsible for some of the variations in haemodynamic patterns between races. These differences may account for the variability in the prevalence of hypertension in different groups. The main aim of this study was to determine whether there was a difference in venous responsiveness to the vasoactive agents, phenylephrine and isoproterenol, between Mexican-Americans and White Americans.
Introduction
Mexican-Americans make up a significant minority group in the United States. Hispanics of Mexican descent, whose racial ancestry is of Native American and Caucasian descent comprise 5.4% of the population of the United States. 1 Compared to White Americans, Mexican-Americans are generally more obese, have a higher incidence and prevalence of non-insulin dependent diabetes mellitus and yet paradoxically have lower rates of hypertension. [2] [3] [4] Several recent reports have addressed the possible association between hyperinsulinaemia, insulin resistance and hypertension. Most but not all studies have found such a relationship. [5] [6] [7] The association between abnormal oral glucose tolerance tests and hypertension has been extended further to include normotensives who have a family history of hypertension. 8 It is therefore puzzling why MexicanAmericans do not have greater rates of hypertension than the population at large.
The lower incidence of hypertension in MexicanAmericans may arise from a protective differential responsiveness to vasoactive substances. Alpha- adrenergic receptors have been implicated in the development of hypertension in that hypertensive subjects are more sensitive to the vasoconstrictive responses produced by ␣-adrenergic stimulation than normotensive subjects. 9, 10 Ethnic variability in the response to ␣-adrenergic mediated stimulation has been previously described. As compared to whites, black subjects have different responses to ␣-adrenergic agonist and antagonists. 11, 12 It is also possible that a differential response to ␤-adrenoceptors may underlie a protective influence against the development of hypertension. Ethnic variability in vascular responsiveness to ␤-adrenergic stimulation has also been ascribed to ␤-adrenergic agonist in blacks 13 and ␤-adrenergic antagonists in Asians. 14 The dorsal hand vein compliance technique is a simple, relatively non-invasive method to study the response to vasoactive substances, in vivo. 15 Doseresponse curves can be constructed and the venodilatory and venoconstrictive effects of pharmacologically active agents can be studied and compared between individual subjects and between groups of subjects. Very small subtherapeutic quantities (1/50 to 1/1000 of normal intravenous dosages) of the test agents are used in the conduct of these experiments, thereby eliminating systemic adverse and compensatory responses. The technique has been used to investigate age-related changes in responsiveness to isoproterenol 16 and to study the effect of aging on responsiveness to nitroglycerin, PGE1, and bradykinin.
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Subjects and methods
Study drugs
Study medications were diluted in normal saline. The drugs used were phenylephrine hydrochloride (1% injection) and isoproterenol hydrochloride (both from Winthrop Laboratories, NY, USA). Phenylephrine was infused in the dosing range of 1-6800 ng/min, while isoproterenol was infused in the dosing range of 2-271 ng/min.
Subjects
Volunteers were all healthy, non-obese and normotensive. Ten Mexican-Americans (5 male, 5 female, mean age 25.4 ± 3.0 years) and 10 Caucasian subjects (7 male, 3 female, mean age 26.7 ± 2.1 years) were studied. To preserve homogeneity, Hispanic subjects included only those of Mexican-American descent dating back three generations. The subjects were admitted on the morning of the study to the Drug Evaluation Unit at Maricopa Medical Center. The subjects signed a written informed consent and underwent a complete physical examination, ECG and routine laboratory tests. Pre-menopausal female subjects were screened for a negative serum pregnancy test within 24 h before the study period. Female subjects were studied midcycle. All subjects were non-smokers and were asked to refrain from caffeine for at least 12 h prior to the study. Table 1 provides details of the baseline characteristics of the volunteers. BMI = body mass index; MAP = mean arterial blood pressure; HR = heart rate.
Dorsal hand vein compliance technique
Studies were conducted with each subject in the supine position with one arm on a padded support sloping upwards at an angle of 30°from the horizontal to allow complete emptying of the veins. The temperature of the room was maintained at 72 ± 2°F during the study period. A suitable vein was chosen on the dorsum of the hand and a 23-gauge needle inserted. A normal saline infusion was started at 0.30 ml/min using a syringe infusion pump. The tripod holding a linear variable differential transformer (LVDT, Shaevitz Engineering, Pennsuaken, NJ, USA) was mounted on the back of the hand with the central aperture of the LVDT over the vein under investigation at a distance of 10 mm downstream from the needle. The central aperture of the LVDT contains a freely moveable core; vertical movement of the core is directly proportional to the signal output of the LVDT, which was recorded on a strip chart recorder. Recordings of the position of the core located on top of the vein were made both before and after inflation of a sphygmomanometer cuff on the arm to 40 mm Hg. This baseline vasodilation during saline infusion with the cuff inflated was defined as 100% relaxation; the recording obtained with the cuff not inflated (and the vein emptied) was defined as 100% constriction (or 0% relaxation).
The difference between the two positions of the core gives a measure of the diameter change of the vein under the given congestion pressure. Baseline recordings were obtained during normal saline infusion after approximately 30 min to allow for equilibrium of the vein after the initial vasoconstriction produced by insertion of the needle. Phenylephrine, an ␣ 1 selective agonist, was used to produce vaso- Table 2 Blood pressure and heart rate at the beginning of the study (pre-) and at the end of the isoproterenol infusion period (post-). There were no significant changes in either heart rate or blood pressure during the study period constriction of the hand vein. A dose-response curve to phenylephrine was performed in each subject (dose range 2-6800 ng/min); and the dose of phenylephrine that produced 80% constriction determined. This dose, or the maximum dose of phenylephrine if 80% venoconstriction was not obtained, was then infused at a constant rate during the subsequent performance of all other dose-response curves. Response to each concentration of the drug was recorded after infusing for at least 5 min, which allowed sufficient time to reach the maximum effect at each infusion rate. Blood pressure and heart rate were regularly monitored in the opposite arm throughout the study period. Table 2 provides information on blood pressure and heart rate in study subjects before and after infusion of isoproterenol.
Data analysis
Individual dose-response curves were analysed with a sigmoid E max model utilising the computer program, MKMODEL (Holford). This iterative nonlinear curve-fitting program provides an estimate of the maximal response (E max ) and the infusion rate producing half maximal response (ED 50 ). A log transformation was performed on individual ED 50 values to obtain geometric means. An unpaired twotailed t-test was used to compare the individual ED 50 values (after log transformation) and the E max values for the subject groups. A value of P Ͻ 0.05 was considered significant.
Results
As shown in Table 3 , the maximal venoconstriction for phenylephrine in the Mexican-American group was less than that of the White Americans (71.2 ± 20.1% vs 89.4 ± 10.9%) (P Ͻ 0.05). The log of the dose of phenylephrine that produced half maximal response (log ED 50 ) was not statistically different between the two subject groups: 2.16 (145 ng/min) ± 0.56 for the Mexican-American group vs 1.91 (80 ng/min) ± 0.49 for the WhiteAmerican group. Dose-response curves from a typi- cal Mexican-American and a typical Caucasian subject are shown in Figure 1 . The maximal venodilatory response to isoproterenol in the MexicanAmericans was 130.0 ± 65.3%; while the maximal venodilatory response to isoproterenol in the White American group was 103.4 ± 66.0% (P = NS). However, the log ED 50 for isoproterenol in the MexicanAmerican group was significantly greater than that of the Caucasian group (1.68 ± 0.35 (47.6 ng/min) vs 1.19 ± 0.55 (15.5 ng/min), P Ͻ 0.05) ( Table 4 ).
Discussion
In this study, there was a difference in venous responsiveness between Mexican-Americans and Caucasians to both the ␣-adrenergic agonist, phenylephrine and the ␤-adrenergic agonist, isoproterenol. The Mexican-American group had less of a maximal venoconstrictive response to phenylephrine, and required a greater infusion rate of isoproterenol to produce a half maximal response. It is possible that one or both of these differences in responsiveness may underlie the low rate of development of hypertension in the Mexican-American population.
Various studies have proposed reasons for interethnic differences in the incidence of hypertension. These factors include environment, plasma renin activity, plasma volume, the kallikrein-kinin system, red cell membrane function and the adrenergic nervous system. 11 These studies have largely been conducted using normotensive and hypertensive White and Black Americans. We are unaware of comparative studies of the adrenergic nervous system involving Mexican-Americans. Factors which have been used to attempt to explain the lower than expected rate of hypertension in Hispanic individuals include genetic influences, lifestyle and cultural factors. 18 In our study the maximal venoconstrictive response to phenylephrine for the Mexican-Americans was less than that obtained in Caucasians. An increase in peripheral vascular resistance is the underlying haemodynamic abnormality in most individuals with essential hypertension. Hyper-responsiveness of vascular smooth muscle to ␣ 1 -and ␣ 2 -adrenoceptor mediated vasoconstriction has been proposed as a factor in maintaining this increased resistance. 19 It is possible that hypo-responsiveness may play a protective role. Other investigators have found that vascular responsiveness to ␣ 1 -adrenergic stimulation with noradrenaline and phenylephrine is enhanced during the development of hypertension. 20 In contrast to ␣-adrenoceptors, it is unclear whether the changes seen in ␤-adrenergic receptors are a cause or a consequence of elevated blood pressure. 21 Changes in ␣-and ␤-adrenergic receptor density may be interlinked in the development of hypertension. Mexican-Americans are a genetic admixture of Caucasian and native American ancestry.
2 Pima Indians, a group that is also hyperinsulinaemic and insulin-resistant 22,23 also do not exhibit a relationship between insulin concentrations and development of hypertension. 24 Our study suggests that normotensive MexicanAmerican subjects may have differential peripheral vascular responsiveness to ␣-and ␤-adrenergic agonist. This change in responsiveness may help explain why factors that normally predispose to the development of hypertension in the White American population may not be as important in Mexican-Americans. The exact mechanism responsible for a protective role against the development of hypertension warrants further investigation.
